Insights from 2024 ASCO® GI Annual Meeting

 

Videos
04:14

Insights from 2024 ASCO® GI Annual Meeting

ASCO® 2024 Insights: "FRESCO-2 Trial - Q-TWiST Analysis of Fruquintinib + Best Supportive Care Compared With Placebo + Best Supportive Care in mCRC"

FEATURING Sebastian Stintzing
  • 39 views
  • June 12, 2024
11:03

Insights from 2024 ASCO® GI Annual Meeting

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripretinib vs. Sunitinib in Pts With Advanced GIST Previously Treated With Imatinib

FEATURING John Zalcberg
  • 178 views
  • March 20, 2024
10:48

Insights from 2024 ASCO® GI Annual Meeting

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Advanced GIST Previously Treated With Imatinib With KIT Exon 11 + 17/18 Mutations

FEATURING John Zalcberg
  • 186 views
  • March 20, 2024
09:19

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "LIBRETTO-001 Study - Durable Efficacy of Selpercatinib in Patients With RET Fusion+ Solid Tumors (Focus on GI Tumors)"

FEATURING Vivek Subbiah
  • 45 views
  • March 5, 2024
10:36

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "Advanced Pancreatic Ductal Adenocarcinoma - Pharmacodynamic Analysis of BPM31510 With Gemcitabine From a Ph2 Study"

FEATURING Madappa Kundranda
  • 80 views
  • February 22, 2024
  • 1
15:18

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "Case Presentation on Upper GI Malignancies - Oligometastatic Esophageal Cancer"

FEATURING Nataliya Uboha
  • 113 views
  • February 22, 2024
  • 2
12:22

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "Neoadjuvant Immunotherapy in Localized MSI-High GI Cancers"

FEATURING Sakti Chakrabarti
  • 60 views
  • February 22, 2024
  • 1
07:41

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "Bi-Weekly FTD/TPI + Bevacizumab vs. FTD/TPI Monotherapy for Chemorefractory mCRC"

FEATURING Hironaga Satake
  • 55 views
  • February 12, 2024
  • 1
15:54

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "Evolving Treatment Paradigms in Rectal Cancer - Personalizing Therapy to Improve Quality of Life - Radiotherapy Perspective"

FEATURING Krishan Jethwa
  • 101 views
  • February 12, 2024
  • 1
05:11

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "INTERCEPT Program of ctDNA Testing for MRD in CRC"

FEATURING Giulia Maddalena
  • 55 views
  • February 12, 2024
19:41

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "Emerging Data and Ongoing Trials With Zanzalintinib, a Novel Multitargeted TKI in CRC"

FEATURING Anwaar Saeed
  • 81 views
  • February 12, 2024
09:32

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "ctDNA in Colon Cancer - GALAXY, BESPOKE, & COBRA Highlights"

FEATURING Yelena Janjigian, Samuel Cytryn, Samuel Klempner
  • 599 views
  • February 7, 2024
  • 5
07:16

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "CheckMate-8HW Clinical Implications - Nivo + Ipi Compared to Chemo in MSI-H/MMR mCRC"

FEATURING Yelena Janjigian, Samuel Cytryn, Samuel Klempner
  • 326 views
  • February 7, 2024
  • 3
09:42

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "MATTERHORN & KEYNOTE-585 Clinical Implications - (Neo)adjuvant IO + Chemo vs. Chemo in Locally Advanced GC & GEJC"

FEATURING Yelena Janjigian, Samuel Cytryn, Samuel Klempner
  • 405 views
  • February 7, 2024
  • 5
06:53

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implications - Paclitaxel & Cisplatin +/- Atezo & Tiragolumab as 1L Treatment for Advanced Esophageal Carcinoma"

FEATURING Yelena Janjigian, Samuel Cytryn, Samuel Klempner
  • 233 views
  • February 7, 2024
  • 2
09:11

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "Evaluating Novel Therapies and ctDNA as a Marker of Response in Curatively Treated Gastrointestinal Cancers With MRD"

FEATURING Reetu Mukherji
  • 148 views
  • February 7, 2024
12:13

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "GALAXY Study in CIRCULATE-Japan - Predicting Recurrence Using a Tumor-Uninformed ctDNA Assay Detecting MRD in Patients With Resected Stage II/III CRC"

FEATURING Kristiyana Kaneva
  • 167 views
  • February 5, 2024
09:56

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, a Novel Methylated ctDNA Therapy Response Monitoring Assay in Patients With Advanced GI Cancer Undergoing Active Treatment"

FEATURING Ilyas Sahin
  • 65 views
  • February 5, 2024
  • 1
11:34

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "NRG-GI005 (COBRA) Study - ctDNA as a Predictive Biomarker in Adjuvant Chemo in Patients With Stage II Colon Cancer"

FEATURING Van Morris
  • 300 views
  • February 1, 2024
  • 5
11:50

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "CRC Key Studies Including BESPOKE & KEYNOTE-177"

FEATURING Richard Kim, Tiago Biachi
  • 473 views
  • February 1, 2024
  • 3
13:58

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 & IMbrave 151"

FEATURING Richard Kim, Tiago Biachi
  • 434 views
  • February 1, 2024
  • 3
04:31

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "NIVOFGFR2 Study - Nivo and CapeOX in Patients With Previously Untreated FGFR2+, PD-L1+ Advanced Gastric Cancer"

FEATURING Ilya Tsimafeyeu
  • 103 views
  • January 31, 2024
04:39

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor Infigratinib vs. Gemcitabine + Cisplatin in Patients With Advanced Cholangiocarcinoma With an FGFR2 Gene Fusion/Rearrangement"

FEATURING Ghassan Abou-Alfa
  • 172 views
  • January 31, 2024
  • 3
05:50

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "KEYSTEP-004 Study - Coformulated Quavonlimab and Pembro in Combination With Lenvatinib as 1L Therapy for Patients With Advanced HCC"

FEATURING Lorenza Rimassa
  • 156 views
  • January 31, 2024
  • 2
07:03

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "FRESCO-2 trial - Quality-Adjusted Time Without Symptoms of Disease or Toxicity Analysis of Fruquintinib + BSC Compared With Placebo + BSC in mCRC"

FEATURING Sebastian Stintzing
  • 150 views
  • January 31, 2024
  • 1
07:35

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including KEYNOTE-585 & MATTERHORN"

FEATURING Richard Kim, Rutika Mehta
  • 488 views
  • January 29, 2024
  • 7
17:23

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key Studies Including KEYNOTE-590 & CheckMate 648"

FEATURING Richard Kim, Rutika Mehta
  • 439 views
  • January 29, 2024
  • 5